$3,500.00
GBI Research’s report: “Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for .....
Published: May-2013
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified.....
Published: Jan-2013
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Autoimmune Disorders Therapeutics Market to 2017 – Launch of Gilenya and Benlysta to Drive the Growth of Mul.....
Published: Apr-2012
|
$3,500.00
Leading business intelligence provider GBI Research has released its latest research report, “Immunomodulators Market to 2017- Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Va.....
Published: Feb-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Solid Organ Transplant Immunosuppressant Market to 2018 – Limited Availability of Donors Drives Improvement.....
Published: Jan-2012
|
$3,500.00
GBI Research’s report, “Immunoglobulins Market to 2017– Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth” provides in-depth analysi.....
Published: Sep-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product.....
Published: Dec-2009
|